News summary

Statins Linked to Reduced Glaucoma Risk and Slower Progression

Source: Neuroscience News • Published: 07 Oct 2026, 18:12

Summarized by Masters of Longevity from Neuroscience News.

This article previews a population-scale observational study examining whether routine statin use is linked to lower glaucoma risk and slower disease progression.

Statins Linked to Reduced Glaucoma Risk and Slower Progression
Key Takeaways
  • Statin users had a 15% lower five-year incidence of open-angle glaucoma compared with matched non-users.
  • Among diagnosed patients, statin exposure was associated with a 55% to 60% reduction in need for laser or surgical interventions.
  • The analysis used propensity-matched cohorts drawn from a federated database covering 165 million individuals and 420,000 studied adults.
Read the full article at Neuroscience News ↗

Continue exploring

Recommended MoL Picks

MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.